Skip to main content
. 2017 Aug 22;5(3):E653–E661. doi: 10.9778/cmajo.20170042

Table 2: Expected costs by category.

Intervention Category; cost, $
Intervention Oral anticoagulant  therapy Ischemic stroke Intracranial hemorrhage Major bleeding Total
PIAAF-Pharmacy screening 66 35 269 55 20 443.98
No screening 0 5 358 41 13 417.93
Incremental 66 29 -90 13 7 26.06

Note: PIAAF-Pharmacy = Program for the Identification of 'Actionable' Atrial Fibrillation in the Pharmacy Setting.